Search

Search Constraints

You searched for: Author/Creator Wiewrodt, Rainer

Search Results

1. 3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases. Issue 1 (31st December 2022)

2. Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience. (27th May 2020)

3. Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities. Issue 1 (1st January 2019)

4. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. Issue 9 (September 2019)

5. Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease. Issue 1 (January 2015)

6. Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease. Issue 1 (January 2015)

7. Epigenetic dysregulation of KCa3.1 channels induces poor prognosis in lung cancer. Issue 6 (29th May 2015)

8. Epigenetic dysregulation of KCa3.1 channels induces poor prognosis in lung cancer. Issue 6 (29th May 2015)

9. Long‐Term Follow‐Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis. (31st December 2020)

10. Long‐Term Follow‐Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis. (31st December 2020)